The Lipopolysaccharide-induced Pro-inflammatory Response in RAW264.7 Cells is Attenuated by an Unsaturated Fatty Acid-bovine Serum Albumin Complex and Enhanced by a Saturated Fatty Acid-bovine Serum Albumin Complex
Overview
Pathology
Affiliations
Objective: A 1:1 ratio of fatty acid (FA)-albumin complex was chosen to mimic physiological conditions, and the effects of FA-bovine serum albumin (BSA) complexes were tested in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells.
Methods: Nitric oxide (NO) and various proteins/factors in RAW264.7 cells were quantified as follows: NO by the Griess assay; prostaglandin (PG) E(2), interleukin (IL)-6 and tumor necrosis factor (TNF)-α by ELISA; inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 by Western blotting; and NF-κB and CD14/TLR4 by Western blotting or flow cytometry.
Results: BSA- or FA-BSA-treated RAW264.7 cells without LPS stimulation did not show any significant changes in NO or the tested proteins/factors and thus did not have any pro-inflammatory responses. Pre-treatment with unsaturated FA-BSA complexes significantly decreased the production of LPS-induced NO, PGE(2), IL-6 and TNF-α, the expression of iNOS, COX-2 and CD14, IκB degradation and NF-κB translocation. On the contrary, pre-treatment with saturated FA-BSA complexes enhanced these LPS-induced pro-inflammatory factors and the subsequent responses.
Conclusions: We concluded that unsaturated FA-BSA complexes, but not saturated FA-BSA complexes, exert an inhibitory effect on the LPS-induced pro-inflammatory response and that this effect may be partially mediated through suppression of the NF-κB signaling pathway. We suggest that an increase of unsaturated FA-BSA complexes may enhance the host's defense against bacterial infection.
Muller A, Albrecht F, Rohrer C, Koeberle A, Werz O, Schlormann W Nutrients. 2021; 13(12).
PMID: 34959989 PMC: 8703532. DOI: 10.3390/nu13124437.
Son H, Xiang H, Park S, Lee J, Lee J, Jung S Int J Environ Res Public Health. 2021; 18(20).
PMID: 34682732 PMC: 8535618. DOI: 10.3390/ijerph182010986.
Zhao Y, Chen Y, Wang J, Zhu X, Wang K, Li Y Mol Med Rep. 2021; 24(2).
PMID: 34080024 PMC: 8188640. DOI: 10.3892/mmr.2021.12194.
Zhang J, Tang X, Huang C, Liu Z, Ye Y Pharmaceutics. 2020; 12(7).
PMID: 32698309 PMC: 7408047. DOI: 10.3390/pharmaceutics12070680.
Psoriasis: Obesity and Fatty Acids.
Kunz M, Simon J, Saalbach A Front Immunol. 2019; 10:1807.
PMID: 31417571 PMC: 6684944. DOI: 10.3389/fimmu.2019.01807.